Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharmaceuticals shares climbed as much as 1.8% on Tuesday to Rs 1,431.25 on the BSE after the company announced that its innovation arm, Ichnos Glenmark Innovation (IGI), has received ‘fast track’ designation from the US Food and Drug Administration (FDA) for its investigational therapy ISB 2001. The designation applies to adult patients with relapsed … Read more
